Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hadassa M, Jochemsen"'
Autor:
Majon Muller, Willem P.Th.M. Mali, Y. van der Graaf, Hadassa M. Jochemsen, Anne M. Grool, Koen L. Vincken, Mirjam I. Geerlings
Publikováno v:
Journal of Alzheimer's Disease. 29:39-49
High levels of angiotensin-converting-enzyme (ACE) may increase the risk of dementia through blood pressure elevation and subsequent development of cerebral small-vessel disease. However, high ACE levels may also decrease this risk through amyloid de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76276dcd71ef741ace5579fdb47924af
https://doi.org/10.3233/jad-2012-111772
https://doi.org/10.3233/jad-2012-111772
Autor:
Yolanda van der Graaf, Frank L.J. Visseren, Ale Algra, Majon Muller, Mirjam I. Geerlings, Hadassa M. Jochemsen
Publikováno v:
Jochemsen, H M, Geerlings, M I, Visseren, F L, Algra, A, van der Graaf, Y & Muller, M 2012, ' Serum angiotensin-converting enzyme and recurrent vascular events. The SMART-MR study ', Atherosclerosis, vol. 224, no. 2, pp. 486-491 . https://doi.org/10.1016/j.atherosclerosis.2012.07.010
Atherosclerosis, 224(2), 486-491. Elsevier Ireland Ltd
Atherosclerosis, 224(2), 486-491. Elsevier Ireland Ltd
Objective Chronic exposure to high levels of angiotensin-converting enzyme (ACE) might increase the risk of hypertensive cardiovascular events. However, little data are available on the association of direct measures of ACE activity with vascular ris
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::846f236971d9bf0e6dd374752172637c
https://hdl.handle.net/1871/42437
https://hdl.handle.net/1871/42437
Autor:
Emma L. Ashby, Charlotte E. Teunissen, Majon Muller, Mirjam I. Geerlings, Hadassa M. Jochemsen, Ruth E. Jones, Mike P. Wattjes, Philip Scheltens, Wiesje M. van der Flier, Patrick G. Kehoe
Publikováno v:
Journal of Alzheimer's Disease, 44(1), 153-162. IOS Press
Journal of Alzheimer's Disease, 44(1), 153-162
Jochemsen, H M, van der Flier, W M, Ashby, E L, Teunissen, C E, Jones, R E, Wattjes, M P, Scheltens, P, Geerlings, M I, Kehoe, P G & Muller, M 2015, ' Angiotensin-Converting Enzyme in Cerebrospinal Fluid and Risk of Brain Atrophy ', Journal of Alzheimer's Disease, vol. 44, no. 1, pp. 153-162 . https://doi.org/10.3233/JAD-131496
Journal of Alzheimer's Disease, 44(1), 153-162
Jochemsen, H M, van der Flier, W M, Ashby, E L, Teunissen, C E, Jones, R E, Wattjes, M P, Scheltens, P, Geerlings, M I, Kehoe, P G & Muller, M 2015, ' Angiotensin-Converting Enzyme in Cerebrospinal Fluid and Risk of Brain Atrophy ', Journal of Alzheimer's Disease, vol. 44, no. 1, pp. 153-162 . https://doi.org/10.3233/JAD-131496
Background Higher angiotensin-converting enzyme (ACE) activity might increase the risk of Alzheimer's disease by increasing blood pressure, and subsequent development of cerebral small vessel disease (CSVD). Yet, it may also decrease this risk, as it
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::287e73d314813683f320a58e38c594b9
https://hdl.handle.net/1887/103147
https://hdl.handle.net/1887/103147
Autor:
Hadassa M. Jochemsen, Mirjam I. Geerlings, Wiesje M. van der Flier, Philip Scheltens, Majon Muller, Emma L. Ashby, Ruth E. Jones, Patrick G. Kehoe, Charlotte E. Teunissen
Publikováno v:
Alzheimer's Research and Therapy, 6(3)
Alzheimer's Research & Therapy, 6(3):27. BioMed Central
Alzheimer's Research & Therapy
Jochemsen, H M, Teunissen, C E, Ashby, E L, van der Flier, W M, Jones, R E, Geerlings, M I, Scheltens, P, Kehoe, P G & Muller, M 2014, ' The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease ', Alzheimer's Research & Therapy, vol. 6, no. 3, 27, pp. 27 . https://doi.org/10.1186/alzrt257
Alzheimer's Research & Therapy, 6(3):27. BioMed Central
Alzheimer's Research & Therapy
Jochemsen, H M, Teunissen, C E, Ashby, E L, van der Flier, W M, Jones, R E, Geerlings, M I, Scheltens, P, Kehoe, P G & Muller, M 2014, ' The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease ', Alzheimer's Research & Therapy, vol. 6, no. 3, 27, pp. 27 . https://doi.org/10.1186/alzrt257
Introduction Lower angiotensin-converting enzyme (ACE) activity could increase the risk of Alzheimer’s disease (AD) as ACE functions to degrade amyloid-β (Aβ). Therefore, we investigated whether ACE protein and activity levels in cerebrospinal fl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5135e3a1b835852bf0a10d0e8140378b
http://hdl.handle.net/1887/103686
http://hdl.handle.net/1887/103686
Autor:
Mirjam I. Geerlings, Majon Muller, Frank L.J. Visseren, Anne M. Grool, Y. van der Graaf, Hadassa M. Jochemsen, Lenore J. Launer
Publikováno v:
Muller, M, Jochemsen, H M, Visseren, F L J, Grool, A M, Launer, L J, van der Graaf, Y & Geerlings, M I 2013, ' Low blood pressure and antihypertensive treatment are independently associated with physical and mental health status in patients with arterial disease: the SMART study ', Journal of Internal Medicine, vol. 274, no. 3, pp. 241-251 . https://doi.org/10.1111/joim.12069
Journal of Internal Medicine, 274(3), 241-251. Wiley-Blackwell
Journal of Internal Medicine, 274(3), 241-251. Wiley-Blackwell
Objective To investigate the independent effects of antihypertensive treatment and blood pressure (BP) levels on physical and mental health status in patients with arterial disease. Design and setting Cross-sectional analyses were conducted within th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80c62ac59183e77f8af8d4d500abeea3
https://research.vumc.nl/en/publications/8d7be2d7-7029-4891-bdc5-ca413780ad74
https://research.vumc.nl/en/publications/8d7be2d7-7029-4891-bdc5-ca413780ad74
Autor:
Hadassa M, Jochemsen, Majon, Muller, Frank L, Visseren, Philip, Scheltens, Koen L, Vincken, Willem P, Mali, Yolanda, van der Graaf, Mirjam I, Geerlings, Frank L J, Visseren
Publikováno v:
JAMA Neurology, 70(8), 1046-1053. American Medical Association
Jochemsen, H M, Muller, M, Visseren, F L, Scheltens, P, Vincken, K L, Mali, W P, van der Graaf, Y & Geerlings, M I 2013, ' Blood Pressure and Progression of Brain Atrophy The SMART-MR Study ', JAMA Neurology, vol. 70, no. 8, pp. 1046-1053 . https://doi.org/10.1001/jamaneurol.2013.217
Jochemsen, H M, Muller, M, Visseren, F L, Scheltens, P, Vincken, K L, Mali, W P, van der Graaf, Y & Geerlings, M I 2013, ' Blood Pressure and Progression of Brain Atrophy The SMART-MR Study ', JAMA Neurology, vol. 70, no. 8, pp. 1046-1053 . https://doi.org/10.1001/jamaneurol.2013.217
Importance Studies have shown that both high and low blood pressure (BP) may play a role in the etiology of brain atrophy. High BP in midlife has been associated with more brain atrophy later in life, whereas studies in older populations have shown a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0deed9e8cca4eed5e1494e1927e8ad75
https://research.vumc.nl/en/publications/ebabb98e-3e1f-4b22-9203-001b3f2256ad
https://research.vumc.nl/en/publications/ebabb98e-3e1f-4b22-9203-001b3f2256ad
Autor:
Hadassa M, Jochemsen, Raoul P, Kloppenborg, Lisette C P G M, de Groot, Ellen, Kampman, Willem P T M, Mali, Yolanda, van der Graaf, Mirjam I, Geerlings, F L J, Visseren
Publikováno v:
Alzheimer's & Dementia 9 (2013) 3
Alzheimers & Dementia, 9(3), 302-309. Elsevier
Alzheimer's & Dementia, 9, 302-9
Alzheimer's & Dementia, 9, 3, pp. 302-9
Jochemsen, H M, Kloppenborg, R P, de Groot, L C P G, Kampman, E, Mali, W P T M, van der Graaf, Y & Geerlings, M I 2013, ' Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study ', Alzheimers & Dementia, vol. 9, no. 3, pp. 302-309 . https://doi.org/10.1016/j.jalz.2011.11.008
Alzheimer's & Dementia, 9(3), 302-309
Alzheimer s & dementia, 9(3), 302-309. Elsevier Inc.
Alzheimers & Dementia, 9(3), 302-309. Elsevier
Alzheimer's & Dementia, 9, 302-9
Alzheimer's & Dementia, 9, 3, pp. 302-9
Jochemsen, H M, Kloppenborg, R P, de Groot, L C P G, Kampman, E, Mali, W P T M, van der Graaf, Y & Geerlings, M I 2013, ' Homocysteine, progression of ventricular enlargement, and cognitive decline: The Second Manifestations of ARTerial disease-Magnetic Resonance study ', Alzheimers & Dementia, vol. 9, no. 3, pp. 302-309 . https://doi.org/10.1016/j.jalz.2011.11.008
Alzheimer's & Dementia, 9(3), 302-309
Alzheimer s & dementia, 9(3), 302-309. Elsevier Inc.
Item does not contain fulltext BACKGROUND: Homocysteine may be a modifiable risk factor for cognitive decline and brain atrophy, particularly in older persons. We examined whether homocysteine increased the risk for cognitive decline and brain atroph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80b9c5b1a0ff87ba00d6cf599c72a314
https://research.wur.nl/en/publications/homocysteine-progression-of-ventricular-enlargement-and-cognitive
https://research.wur.nl/en/publications/homocysteine-progression-of-ventricular-enlargement-and-cognitive
Publikováno v:
Jochemsen, H M, Muller, M, van der Graaf, Y & Geerlings, M I 2012, ' APOE epsilon 4 differentially influences change in memory performance depending on age. The SMART-MR study ', Neurobiology of Aging, vol. 33, no. 4, pp. 832.e15-832.e22 . https://doi.org/10.1016/j.neurobiolaging.2011.07.016
Neurobiology of Aging, 33(4), 832.e15-832.e22. Elsevier Inc.
Neurobiology of Aging, 33(4), 832.e15-832.e22. Elsevier Inc.
The apolipoprotein E (APOE) gene may act differently in young and old persons, known as antagonistic pleiotropy. We therefore examined the prospective associations between the APOE ε4 allele and cognitive functioning, and the modifying effect of age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8103925f5382a74b859a54e63813be4f